Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizo-Affective Type of Psychosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00139919
What this trial is testing

Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder
Solvay Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT06340789
What this trial is testing

Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate

Who this might be right for
Symptom, CognitiveSchizophreniaSchizo Affective Disorder
National Cheng-Kung University Hospital 90
Not applicableStudy completedNCT00914238
What this trial is testing

Extended Specialized Assertive Intervention for First Episode Psychosis

Who this might be right for
First Episode Psychosis of Schizophrenia and Schizotypal DisorderPsychotic DisordersSchizophrenia+1 more
University of Copenhagen 400
Very early researchStudy completedNCT03671525
What this trial is testing

Cognitive Effects of Nimodipine in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizo Affective Disorder
Johns Hopkins University 18
Post-approval studies (Phase 4)WithdrawnNCT00964041
What this trial is testing

Once Weekly D-cycloserine for Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT00709202
What this trial is testing

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+5 more
Nathan Kline Institute for Psychiatric Research 48
Post-approval studies (Phase 4)UnknownNCT00469664
What this trial is testing

Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderCognitive Impairment
Research Foundation for Mental Hygiene, Inc. 50
Not applicableStudy completedNCT00179062
What this trial is testing

Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderDepressive Disorder, Major+1 more
Vanderbilt University 300
Not applicableUnknownNCT02986490
What this trial is testing

Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder
University Hospital, Montpellier 100
Not applicableStudy completedNCT02085447
What this trial is testing

A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness

Who this might be right for
Psychotic DisordersSchizophreniaSchizoaffective Disorder+2 more
University Hospitals Cleveland Medical Center 30
Not applicableStudy completedNCT05204407
What this trial is testing

Luteolin for the Treatment of People With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Maryland, Baltimore 85
Large-scale testing (Phase 3)Study completedNCT00088465
What this trial is testing

Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Schizophrenic DisordersSchizoaffective Disorder
Eli Lilly and Company 931
Not applicableStudy completedNCT03208036
What this trial is testing

Restoration of Cognitive Function With TDCS and Training in Serious Mental Illness

Who this might be right for
SchizophreniaBipolar DisorderSchizo Affective Disorder
VA Office of Research and Development 22
Post-approval studies (Phase 4)Study completedNCT02124811
What this trial is testing

Minocycline Augmentation to Clozapine

Who this might be right for
SchizophreniaSchizoaffective Disorder
Emory University 10
Not applicableStudy completedNCT00108199
What this trial is testing

Generalization of Training in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
US Department of Veterans Affairs
Not applicableUnknownNCT02529163
What this trial is testing

Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic Symptoms

Who this might be right for
SchizophreniaSchizoaffective Disorder
Centre for Addiction and Mental Health 24
Post-approval studies (Phase 4)Study completedNCT00458211
What this trial is testing

Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics

Who this might be right for
SchizophreniaSchizoaffective Disorder
Bronx Psychiatric Center 40
Not applicableUnknownNCT02159001
What this trial is testing

Electroconvulsive Therapy in Clozapine-resistant Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Niuvanniemi Hospital 20
Post-approval studies (Phase 4)Study completedNCT00646581
What this trial is testing

Effect of Single Dose Intranasal Insulin On Cognitive Function

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Massachusetts, Worcester 30
Testing effectiveness (Phase 2)Study completedNCT07116694
What this trial is testing

Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder

Who this might be right for
Bipolar I DisorderBipolar II DisorderSchizophrenia+3 more
BioXcel Therapeutics Inc 33
Next Page